Peripartum cardiomyopathy: current understanding, comprehensive management review and new developments
1Cardiology Department, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Prescot Street, Liverpool L7 8XP, UK. jason.pyatt@rlbuht.nhs.uk
Postgraduate Medical Journal
|October 12, 2010
Summary
Peripartum cardiomyopathy (PPCM) is a rare heart condition affecting pregnant women. While some recover fully, recurrence risk is high if heart function doesn't normalize, but subsequent pregnancies may be low-risk if function is restored.
Area of Science:
- Cardiology
- Maternal-Fetal Medicine
- Reproductive Medicine
Background:
- Peripartum cardiomyopathy (PPCM) is a rare, potentially fatal heart failure condition.
- It presents with left ventricular (LV) systolic dysfunction late in pregnancy or postpartum.
- Etiology is largely unknown, but a prolactin derivative and oxidative stress are implicated.
Purpose of the Study:
- To summarize the understanding of peripartum cardiomyopathy.
- To outline current management strategies and risks.
- To discuss prognosis and recurrence in subsequent pregnancies.
Main Methods:
- Review of existing literature on peripartum cardiomyopathy.
- Analysis of clinical presentation, diagnosis, and management.
- Evaluation of outcomes, including recovery and recurrence rates.
Main Results:
- PPCM involves LV systolic dysfunction, with onset typically in late pregnancy or postpartum.
- Management parallels other non-ischemic cardiomyopathies, prioritizing maternal-fetal safety.
- Venous thromboembolism risk is elevated, necessitating anticoagulation.
Conclusions:
- Approximately 30-50% of PPCM patients achieve full LV systolic function recovery.
- High recurrence risk exists if LV function remains impaired.
- Subsequent pregnancies carry low risk for women with normalized LV function.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...